CAMBRIDGE, England & BOSTON, Mass.--(BUSINESS WIRE)--Linguamatics, the leader in natural language processing (NLP)-based text mining, announced today that the FDA’s Center for Drug Evaluation and Research (CDER) has licensed its I2E text mining platform to support laboratory research efforts on drug safety. Financial details of the agreement were not disclosed.